ETFMG Alternative Harvest ETF

The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.

In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.

In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.

Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.

Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

On December 9, Canopy Growth (CGC) appointed David Klein as its new CEO effective January 14. He’s the current CFO of Constellation Brands.

As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.

The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?

With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.

As the cannabis space has increasingly become crowded, companies such as Cronos Group would greatly benefit from a company such as Altria.

GW Pharmaceuticals has received a “strong buy” rating from four analysts, while eight have rated it as a “buy” or some equivalent.

As the demand for Cannabis 2.0 products continues to rise, Aurora Cannabis announced the appointment of Miguel Martin as its new chief commercial officer.

Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.

The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.

Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.

Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.

Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.

Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.

Canopy Growth (NYSE:CGC)(TSE:WEED) stock rose to a high of 22.66 Canadian dollars before closing at 21.46 Canadian dollars on Monday.

As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.

On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.

Acquisitions could boost Curaleaf’s production and retail footprint significantly. With the EBITDA expected to rise over the next two years, there’s significant upside.

On January 10, HEXO was trading at 1.74 Canadian dollars, a fall of 63.1% since the beginning of 2019 and a discount of 84.6% to its 52-week high.

On January 12, GW Pharmaceuticals announced its preliminary unaudited product sales report for the fourth quarter and 2019.

KushCo Holdings reported its Q1 earnings on January 8. KushCo reported revenue of $34.96 million, below analysts’ forecast of $41.5 million.

TerrAscend’s recent private placement was oversubscribed due to strong investor interest. It increased the offering to about $30 million from $20 million.

Today, Aurora Cannabis (ACB) was trading 11.2% higher at 12:06 PM ET. The company had lost 63.3% of its stock value YTD as of Monday.

Warren Buffett is one of the greatest value investors in the world. He’s invested in companies across various sectors, but he’s avoided cannabis. Why?

Jim Cramer expressed disappointment with the cannabis industry, claiming it may not be the “incredible opportunity” he thought it was.

Aurora Cannabis reported its third-quarter results after the market closed on November 14. Despite some positives, it fell 18% on November 15.

After closing in the red yesterday, the US equity market was trading marginally higher today. The cannabis sector is also up—and here’s why.

As of October 4, Aurora Cannabis was trading at a forward EV-to-EBITDA multiple of 33.05x compared to 68.8x at the beginning of September.

Aurora Cannabis posted its fourth-quarter earnings after the market closed on Wednesday. The company posted revenues of 98.9 million Canadian dollars.

Aurora Cannabis (ACB) stock has been rising before its fourth-quarter earnings on Thursday. The stock has risen 12.4% this month.

Before the market opened on March 28, CannTrust (CTST) reported its Q4 2018 and full-year earnings.